Jean-Pierre Garnier

Operating Partner at Advent International Corp.

Jean-Pierre Garnier

Jean-Pierre Garnier

Operating Partner at Advent International Corp.

Overview
Career Highlights

Schering-Plough’s US business
e.Nvizion Communications Group Ltd.
Schering-Plough Corporation

RelSci Relationships

2661

Number of Boards

22

Birthday

10/1947

Age

72

Number of Awards

1

Relationships
RelSci Relationships are individuals Jean-Pierre Garnier likely has professional access to. A relationship does not necessarily indicate a personal connection.

Former President, Pharmaceuticals at GlaxoSmithKline Plc

Relationship likelihood: Strong

Chief Executive Officer & Director at Idorsia Ltd.

Relationship likelihood: Strong

Chairman at Max Planck Florida Corporation

Relationship likelihood: Strong

Former President & Chief Financial Officer at Bausch + Lomb, Inc.

Relationship likelihood: Strong

Chairman of the Board, President & Chief Executive Officer at United Technologies Corporation

Relationship likelihood: Strong

Director at PTS Intermediate Holdings LLC

Relationship likelihood: Strong

Founder at Alzheon, Inc.

Relationship likelihood: Strong

Chief Executive Officer at PostNL NV

Relationship likelihood: Strong

Co-Founder at Actelion Ltd.

Relationship likelihood: Strong

Clinical Professor, Department of Psychiatry at Georgetown University - School of Medicine

Relationship likelihood: Strong

Paths to Jean-Pierre Garnier
Potential Connections via
Relationship Science
You
Jean-Pierre Garnier
Operating Partner at Advent International Corp.
Education
MBA
Class of 1974

The Stanford Graduate School of Business has built an international reputation based on its innovative programs, which include: Two-year MBA Program, designed to educate business leaders One-year Stanford Sloan Master’s Program for mid-career executives PhD Program for future academics Executive Education programs for experienced managers Faculty research program Academic programs, including the two-year MBA, the 12-month Sloan Master's Program, and the PhD program, create a transformational student experience that reflects the tagline: Change lives. Change organizations. Change the world. Today the state-of-the-art Knight Management Center complex enables Stanford's innovative, globalized MBA curriculum, offering flexible classroom spaces for hands-on experiential learning small-group leadership labs, and team-based learning. It engages faculty and students across Stanford University, as well as alumni, global executives, and the broader world community.

MS in Pharmaceutical Science

University of Strasbourg is an institute of higher education that is located in France.

Ph.D Pharmacology

Louis Pasteur University is a school.

Career History
Operating Partner
Current

Advent International was founded in 1984 and is one of the largest and most experienced global private equity firms. With offices on four continents, they have established a globally integrated team of over 180 investment professionals, focused on buyouts and growth equity investments in five core sectors. Since initiating their private equity strategy in 1989, they have invested $33 billion in 325 transactions across 40 countries, and as of December 31, 2016, managed $41 billion in assets.

Chief Executive Officer
Prior

Smithkline Beecham Plc develops and manufactures pharmaceutical products. The company markets pharmaceuticals for human and animal healthcare consumption, vaccines, over the counter medicines, health related consumer products, clinical laboratory testing services, disease management and pharmaceutical benefit management. It is headquartered in Brentford, UK.

Advisor
Prior - 2010

Quaker Partners invests in the life science sector including biopharmaceuticals, medical devices, human diagnostics, specialty pharmaceuticals and healthcare services. They are particularly interested in companies developing human therapeutic products as well as companies pursuing platform technologies for the biopharmaceutical industry. The firm invests across all stages of development, with emphasis on development stage companies.

Boards & Committees
Member, Board of Trustees
Current
Chairman
Prior - 2014

ABIONYX Pharma SA is a biopharmaceutical company, which engages in discovery and development of novel therapies based on high-density lipoproteins and the metabolism of lipids for the treatment of associated cardiovascular and metabolic diseases. Its therapies consist of CER 001 and 209. The company was founded by Jean-Louis Dasseux and William F. Brinkerhoff on March 24, 2005 and is headquartered in Labege, France.

Director
2008 - 2010

Pierre Fabre Participations SASU operates as a holding company with interests in the manufacture of chocolate and cocoa products. The company is headquartered in Paris, France.

Director
Current

At the Max Planck Institute molecular immunologists, developmental geneticists, cell biologists and biochemists have been brought together to investigate the generation and function of the immune system, development of vertebrate embryos, cell signalling and the regulation of gene expression. In addition, Epigenetic research is another focus at the institute. State-of-the-art technologies and model organisms are used to unravel the mechanisms underlying these biological processes.

Member, Board of Directors
Prior

Founded in 1898, and affiliated with what is now NewYork-Presbyterian Hospital since 1927, Weill Cornell Medical College is among the top-ranked clinical and medical research centers in the country. In addition to offering degrees in medicine, Weill Cornell also has PhD programs in biomedical research and education at the Weill Cornell Graduate School of Medical Sciences, and with neighboring Sloan-Kettering Institute and The Rockefeller University, has established a joint MD-PhD program for students to intensify their pursuit of Weill Cornell's triple mission of education, research, and patient care. Weill Cornell Medical College is divided into 24 basic science and patient care departments that focus on the sciences underlying clinical medicine and/or encompass the study, treatment, and prevention of human diseases. In addition to its affiliation with NewYork-Presbyterian Hospital, Weill Cornell Medical College and the Weill Cornell Graduate School of Medical Sciences maintain major affiliations with Memorial Sloan-Kettering Cancer Center, The Rockefeller University, the Hospital for Special Surgery, as well as with the metropolitan-area institutions that constitute NewYork-Presbyterian Healthcare Network. Weill Cornell Medical College and the Weill Cornell Graduate School of Medical Sciences are accredited by the Liaison Committee for Medical Education of the American Medical Association and the Association of American Medical Colleges.

Non-Profit Donations & Grants

Learn how non-profit organizations benefit from RelSci
N/A
2006

The New York Academy of Sciences is a membership organization with over 25,000 members in 140 countries. They include research scientists at universities and industry, as well as representatives of business, government, and policy organizations. Our Board of Governors and President's Council include 27 Nobel laureates and other prominent leaders of academia and industry, based in New York and around the world.

Political Donations
$10K
2007

The National Republican Congressional Committee (NRCC) is the Republican Hill committee which works to elect Republicans to the United States House of Representatives. The NRCC was formed in 1866, when the Republican caucuses of the House and Senate formed a "Congressional Committee". It supports the election of Republicans to the House through direct financial contributions to candidates and Republican Party organizations; technical and research assistance to Republican candidates and Party organizations; voter registration, education and turnout programs; and other Party-building activities.

Public Holdings
Restricted data only for RelSci Professional users.
Awards & Honors
2009
Knight Commander of the Order of the British Empire
Events
Attendee
New York City, NY
2007 Board of Boards CEO Conference

Board of Boards CEO Roundtable, consistently rated one of the world's top executive gatherings, is a unique opportunity for corporate leaders to share insights and best practices and to help advance the business case for corporate community investment. By coming together for this event, global CEOs demonstrate their commitment to CECP’s mission — to draw together and empower senior executives of the world's largest companies to make unprecedented progress on societal challenges while driving business performance.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Jean-Pierre Garnier. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Jean-Pierre Garnier's profile does not indicate a business or promotional relationship of any kind between RelSci and Jean-Pierre Garnier.